Delivery Order SPE2DB20D1100-SPE2DB25FC8F3
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of DUPIXENT 200 MG/1.14 ML PEN 1.14ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $8,974.55, is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through March 5, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
The federal contract award is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The fixed-price delivery order has a ceiling value of $20,513.52 and a completion date of January 8, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $12,125.46 firm fixed price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 16, 2025 with a completion date of May 19, 2025. This contract is not set aside and was awarded under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $10,257.35, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of July 18, 2024. The contract does not have a set-aside designation, indicating open...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $56,253.69 firm fixed-price delivery order contract has a completion date of February 25, 2025. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a ceiling value of $13,336.96. It is a delivery order contract with a firm fixed price pricing type. The ultimate completion date is January 11, 2024. This contract award is not...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The $54,563.21 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024, with a completion date of December 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $79,621.50 and a completion date of June 4, 2024. The award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $30,041.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 10, 2025 with a completion date of June 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
The federal contract award is for the delivery of pharmaceutical products, specifically DUPIXENT 300 MG/2 ML PEN 2ML, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $25,528.67 and is a Firm Fixed Price Delivery Order that runs through January 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...